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Abstract
Mitochondrial membrane permeability has received considerable attention recently because of its key role in apoptosis and
necrosis induced by physiological events such as hypoxia. The manner in which mitochondria interact with other molecules
to regulate mitochondrial permeability and cell destiny remains elusive. Previously we verified that hypoxia-induced
phosphorylation of microtubule-associated protein 4 (MAP4) could lead to microtubules (MTs) disruption. In this study, we
established the hypoxic (1% O2) cell models of rat cardiomyocytes, H9c2 and HeLa cells to further test MAP4 function. We
demonstrated that increase in the pool of MAP4 could promote the stabilization of MT networks by increasing the synthesis
and polymerization of tubulin in hypoxia. Results showed MAP4 overexpression could enhance cell viability and ATP
content under hypoxic conditions. Subsequently we employed a yeast two-hybrid system to tag a protein interacting with
mitochondria, dynein light chain Tctex-type 1 (DYNLT1), by hVDAC1 bait. We confirmed that DYNLT1 had protein-protein
interactions with voltage-dependent anion channel 1 (VDAC1) using co-immunoprecipitation; and immunofluorescence
technique showed that DYNLT1 was closely associated with MTs and VDAC1. Furthermore, DYNLT1 interactions with MAP4
were explored using a knockdown technique. We thus propose two possible mechanisms triggered by MAP4: (1)
stabilization of MT networks, (2) DYNLT1 modulation, which is connected with VDAC1, and inhibition of hypoxia-induced
mitochondrial permeabilization.
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Introduction
Mitochondria are membrane enclosed organelles found in most
eukaryotic cells [1]. The organelle consists of components or
compartments that carry out specialized functions. These
compartments or regions include the outer and inner membranes,
intermembrane space, cristae, and matrix. Mitochondria are
crucial for cellular function and have been described as ‘‘cellular
powerhouses’’ because they generate most of the cell’s ATP
supply, which is used as the most important source of chemical
energy. In addition to supplying cellular energy, mitochondria
may play critical roles in a wide range of cytophysiological
processes such as cell signaling, differentiation, cell death, as well
as control of the cell cycle and growth [2]. Mitochondria have
been implicated in several human diseases and cardiac dysfunction
[3].
The induction of mitochondrial permeability transition (mPT)
can cause mitochondrial depolarization to the point where the
mitochondrial membrane potential (MMP) is abolished. When the
MMP is lost there is an uninhibited flow of protons and various
molecules across the outer mitochondrial membrane [4,5]. The
loss of the MMP also interferes with the production of ATP
because the mitochondrion must have an electrochemical gradient
to provide the driving force for ATP production. During the cell
damage resulting from severe hypoxemic injury of the organism,
such as a heart attack or severe burn, an induced permeabilization
can severely reduce ATP production and even cause ATP synthase
to start hydrolyzing ATP rather than producing it [6]. Many
molecular chaperones are associated with mPT stabilization [7].
An increase in MMP is one of the key events in apoptotic and
necrotic cell death that is purportedly regulated by various
channels, for example the voltage-dependent anion-selective
channel (VDAC), an outer membrane porin that also mediates
the exchange of metabolites and energy between the cytosol and
the mitochondria. Recent studies by Bernardi [8] and Molkentin
[9] have raised doubts about the essential nature and involvement
of some VDAC isoforms in the outer membrane mPT pore
because knockout mice continue to express mPT pore activity.
Nevertheless, VDAC continues to be put forward as a part of the
permeabilization mechanism in normal cells; it also may be a
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of cytochrome c, and thus an apoptosis-inducing factor [10,11,12].
Mitochondria are distributed with the aid of the cytoskeleton.
Microtubules (MTs) are polymers of a- and b-tubulin dimers and
have been assigned many functional roles in protein synthesis,
intracellular trafficking, mitosis, cytokinesis, intracellular signaling,
and cell fate determination [13,14], when the ischemia-reperfusion
and calcium overload occurring, the MTs are more prone to
damage than the actin filaments [15]. Microtubule-associated
proteins (MAPs) bind to tubulin subunits that make up MTs in
order to regulate their stability. A variety of MAPs have been
identified in different cell types and they perform various functions,
for example, the fine tuning of MT dynamics to stabilize and
destabilize MTs when guiding MTs towards specific cellular
locations, MT cross-linking, and mediating interactions between
MTs and other proteins [16,17,18]. MAP4 is found in nearly all cell
types and is responsible for stabilization of MTs [19]. Takahashi
et al. [20] reported that overexpression of MAP4 caused a shift of
tubulin dimers to a polymerized fraction and formed dense, stable
MT networks; overexpression also caused elevated tubulin
expression and altered MT network properties [21]. Hypoxic stress
can influence cell state whereby MAPs may be induced to act in a
protective role by influencing MTs. Cortical neurons thrive under
hypoxic conditions (1% O2) for significantly longer (7–14 days) than
neurons cultured under ambient conditions (20% O2). One possible
explanation is that this is due to the expression of MAP2 and the
robust development of dendritic structure [22]. In contrast, our
previous study [23] showed that hypoxia decreased cell viability and
hypoxia-induced MAP4 phosphorylation lead to MT network
disruption and an increase in free tubulin.
MTs function in concert with specialized dynein motors that are
oriented such that the light chain portion is attached to cell
organelles (e.g. mitochondria) and the dynamic portion is attached
to MTs. Cytoplasmic dynein is the major motor protein complex
responsible for MT-based motile processes. Dynein is an
approximately twelve subunit complex consisting of two heavy
chains, two intermediate chains anchored to its cargo, four smaller
intermediate chains, and several light chains [24,25,26]. Schwar-
zer et al. [27] reported that Dynein light chain Tctex-type 1
(DYNLT1) slightly increases the voltage-dependence of VDAC1,
indicating that DYNLT1 can modulate channel properties.
The above data indicate that under hypoxic conditions the
disruption of MT networks may be a deciding factor in
mitochondrial permeabilization and that MAP4 is involved as a
potential modulator. We hypothesized that MAP4 may play a
cytoprotective role by stabilizing MTs and by modulating
DYNLT1, which is connected to VDAC1 and responsible for
mPT induction and an MMP decrease. We show that MAP4
overexpression can alleviate the loss of ATP and DYNLT1 can
diminish mPT by interacting with VDAC1 during hypoxia. Thus,
we provide new insights into a MAP4 mechanism that stabilizes
mitochondria and improves cell viability.
Results
Increase in the pool of MAP4 contributes to an increase
in the structure of cytoplasmic MTs in both of
cardiomyocytes and HeLa cells
In most cells, MAP4 can promote the addition of cytoplasmic
tubulin dimers to the ends of MTs, consequently increasing the
amount of MTs. We transfected neonatal rat ventricular cardiomy-
ocytes (CMs) and HeLa cells with an adenovirus vector containing
MAP4 cDNA (Ad-MAP4; +MAP4-CMs, +MAP4-HeLa cells).
Western blot analysis indicated that the expression of dephosphor-
ylated MAP4 was significantly elevated in +MAP4-CMs and
+MAP4-HeLa cells, whereas no such differences were seen in non-
transfectedcells (Ngroup)orcellstransfectedwithAd-GFP(Ad-GFP
group) (Figure 1A, P.0.05). We chose a-tubulin as representative of
the cytoplasmic tubulin pool. The constitutive quantity of a-tubulin
in +MAP4 -CMs and -HeLa cells after transfection was muchhigher
than that seen in the N and Ad-GFP groups (Figure 1B, P,0.01).
Confocal laser microscopy suggested that the amount of MAP4
(FITC-green) was much higher and the structure of MTs (TRITC-
red) more luxuriant in +MAP4 (CMs and HeLa cells) than those
in control cells (non-transfected). The merged images indicate
that a plentiful amount of MAP4 was inserted into the MT
structure, and apparently promoted the assembly of cytoplasmic
MTs (Figure 1C, 1D).
Elevated cytoplasmic MAP4 alleviates hypoxia-induced
MTs disruption
Tubular complexes are formed with a/b-tubulin heterodimers
in the cytoplasm, and a dynamic balance exists between the
assembly and disassembly of MTs. Hypoxia can destabilize this
balance and instantly promote disassembly, even in the early
stages of hypoxia (,30 min). The confocal images in Figure 2A
and 2B show that after 30 min of hypoxia the structure of the MTs
(FITC-green) was severely disrupted in both CMs and HeLa Con
(non-transfected) groups, whereas in the +MAP4 groups, this
collapse was retarded (Figure 2B-i), especially during the early
stage of hypoxia. Figure 2B-c illustrates that the MT disruption
was initiated around the periphery of the cell adjacent to the
cytomembrane (60 min, P,0.01); this disruption then spread to
entire cell as the hypoxic duration increased. Interestingly, in the
early hypoxia condition MTs assembly in +MAP4 HeLa cells
seemed enhanced near the cytomembrane (Figure 2A-g, h) but as
hypoxia continued the MT network was more concentrated within
the cytoplasm (Figure 2A-i) and subsequently faded away after
360 min of hypoxia (Figure 2A-j).
Quantification of fluorescent intensity levels showed that MT
networks in +MAP4 CMs cells remained significantly higher versus
control for at least 60 min of hypoxia (P,0.01), but that fluorescent
intensity then dramatically declined and was not significantly
different from control values at 180 min (P.0.05). Similar
differences were noted in HeLa cells, although +MAP4 HeLa cells
maintained significantly higher fluorescent values for longer
(180 min) compared with control cells. Note that fluorescent
intensity in +MAP4 normoxic cells were, in some cases, consider-
ably higher than control values, particularly in the case of CMs.
Protein-protein interactions between VDAC1 and
DYNLT1; co-localization with MTs in the cytosol
In order to find a molecule that linked MT networks and
mitochondria, a Yeast two-hybrid system was employed to tag
potentially new molecules using hVDAC1 as bait. The final
candidate tested was DYNLTD1 (Figure 3A, Table 1). DYNLT1
is an integral component of the dynein complex, via the dynein
heavy chain, interacts with MT networks [24,26,28,29]. Applied
bioinformatics analysis, we speculated that there was a possible
connection between DYNLT1 and VDAC1. As shown in
Figure 3B, whole-cell CM and HeLa cell lysates contained a
great deal of VDAC1 in an antigen-antibody complex based on a
goat / rabbit anti-DYNLT1 antibody application. In a separate
experiment using an anti-VDAC1 antibody, we showed that
DYNLT1 was also detected in the co-immunoprecipitate.
Our next question concerned the morphological relationship
between these three factors: DYNLT1, VDAC1 and MTs.
MAP4 Stabilizes mPT in Hypoxia via MTs and DYNLT1
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in the distribution of DYNLT1 (FITC-green) and VDAC1 (TRITC-
red) (Figure 3C), and thus demonstrated their co-localization and
the link between them. Imaging showed DYNLT1 (FITC-green)
was widely distributed in the cytoplasm and the density of
DYNLT1 was obviously higher along MTs (TRITC-red)
(Figure 3D). Previous studies have proposed that DYNLT1 is
involved in Dynein formation, whose main function is cargo
transportation. Thus, our results indicate that DYNLT1, VDAC1
and MTs are co-localized within the cytoplasm.
MAP4 overexpression leads to elevated expression of
cytoplasmic DYNLT1
The above data showed that overexpression of MAP4 led to
elevated expression of tubulin (Figure 1B). We used western blot
analysis to determine if +MAP4 also resulted in an increased
expression of DYNLT1 (Figure 4A). A significantly elevated
expression of DYNLT1 was also detected in +MAP4 HeLa cells
(P,0.01). Transient transfection of a plasmid to increase
DYNLT1 in HeLa cells (Figure 4B) shows that DYNLT1 was
overexpressed accordingly, but there appeared no concomitant
increase in MAP4 or a-tubulin (Figure 4C).
MAP4 overexpression contributes to the maintenance of
hypoxic energy metabolism
Con and +MAP4 groups of CMs and HeLa cells were
established and exposed to hypoxic conditions for 30, 60, 180
and 360 min. The relative cellular viability of the cultured cells
was tested using the MTT method. Figure 5A illustrates that the
+MAP4 CMs were more viable than control CMs at all times after
60 min. +MAP4 HeLa cells showed an earlier resistance to
hypoxia compared to controls and CMs in MTT reduction after
Figure 1. MAP4 overexpression increases the amount of a-tubulin and MT networks. A and B, Western blots showed that the expression
of MAP4 and gross quantity of a-tubulin in HeLa cells and CMs after Ad-MAP4 was elevated after transfection. Graphs represent the mean6SEM of
the relative optical density signals for three separate experiments (n=3). N - non-transfected cells. # P,0.01 vs. N and Ad-GFP, Student’s t test
analysis. Cytosol GAPDH was chosen as the internal control. C and D, Immunofluorescent confocal micrographs of HeLa cells and CMs. Micrographs
show that cells contain a larger amount of MAP4 (FITC-green) and more luxuriant MT network structure (TRITC-red) after Ad-MAP4 transfection
compared with Con (Non-transfected cells). Scale bar, 10 mm.
doi:10.1371/journal.pone.0028052.g001
Figure 2. MAP4 overexpression alleviates MT disruption during the early stages of hypoxia. Immunofluorescent confocal micrographs of
+MAP4 and Con (Non-transfected) HeLa cells (A) and CMs (B) under normoxia and hypoxia. Micrographs show the changes in MTs as hypoxia
duration is increased. Graphs to the right represent the corresponding % Integral optical density of MTs (green) (IOD; values were normalized as
percentage after comparison with normal, which were set to 100%; n=3). Results show that the structure of MTs was significantly disrupted after
30 min of hypoxia in Con groups, while in +MAP4 groups this disruption was less apparent until 60 min. +MAP4 cells seemed to contain more MTs
than Con cells undergoing the same level of hypoxia, especially at the earlier time points (#60 min in CMs; #180 min in HeLa cells). All values are
mean6SEM. * P,0.05, # P,0.01, vs. Con at each time point, Student’s t test analysis; { P,0.05, J P,0.01, vs. Norm (Normoxia) within each group,
One-way ANOVA followed by Tukey’s post-hoc tests. Scale bar, 10 mm.
doi:10.1371/journal.pone.0028052.g002
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significant at 360 min (P.0.05). Figure 5B illustrates that in either
cell category, the relative ATP content in the +MAP4 group was
significantly higher than that in the control cells between 30 and
180 min, after which ATP quantity fell to low levels and by
360 min no significant difference was detected.
There is a degree of variability between CMs and HeLa cell
responses at two time points: 30 and 360 min in Figure 5A. This
might be due to inherent differences between the HeLa and CM
cells in their ability to withstand hypoxia.
DYNLT1 knockdown aggravates hypoxia-induced
mitochondrial damage: permeabilization, MMP collapse
and metabolic viability reduction
The H9c2 cell line, a subclone of the original clonal cell line
derived from embryonic BD1X rat heart tissue, was chosen
instead of CMs in order to establish stable cell lines with a
knockdown of DYNLT1 (2DYNLT1) after the RNA interference
technique. We used a shRNA vector to knockdown the DYNLT1
because of the confirmed protein-protein interactions between
DYNLT1 and VDAC1, and then established and verified which
subclones had a low and stable expression of DYNLT1 (i.e. HeLa-
dD and H9c2-dD cells). The effect of DYNLT1 down-regulation
was analyzed with Western blots (Figure 6). As shown in Figure 7A
and 7B, the DYNLT1 knockdown aggravated hypoxia-induced
MMP damage and mPT followed by mitochondrial injury; this
damage was not ameliorated by +DYNLT1 (DYNLT1 overex-
pression). Figure 7C shows that the depletion of DYNLT1
(2DYNLT1) under hypoxic conditions caused a sharp decrease
in relative cell viability. On the other hand, DYNLT1 overex-
pression did not effectively protect the cell from hypoxia-induced
damage compared with the WT (non-transfected) group.
Discussion
Hypoxic-ischemic injury is the result of oxygen lack, a condition
that extensively occurs as a primary complication of heart
dysfunction, stroke, and severe burn wounds. Mitochondria are
crucial organelles that trigger or facilitate cell disruption under
hypoxic conditions. Increasing attention has been directed towards
mPT because induced permeabilization will cause matrix swelling,
MMP loss and cellular energy dysmetabolism. VDAC has been
proposed as an important channel located in the outer membrane.
Among the three isoforms, VDAC1 is the most abundant porin
isoform in mammals. Despite the controversy about VDAC1’s
essential involvement in mPT pore components, it is widely
accepted that VDAC1 serves as master regulator of mPT and
consequently mitochondrial function by allowing exchange of ions
and metabolites between the intermembrane space and cytosol,
and the release of apoptotic proteins, such as cytochrome C, into
the cytosol. Therefore, an increasing number of recent studies
have focused on VDAC as a means of protecting the organism
against hypoxic damage [10,11,12].
MTs are an important element of the cytoskeleton that supports
the distribution of mitochondria in the cytosol. Our previous study
on CMs and HeLa cells [23] suggested that the collapse of MT
networks develops quickly during hypoxia, such that, within 15 min
after the onset of hypoxia the MT networks have begun partial
depolymerization. This damage preceded cellular energy dysfunc-
tion. Nevertheless, the manner in which MTs function during
hypoxia and the link between MTs and mitochondria remained
elusive. We also observed that hypoxia-induced MAP4 phosphor-
ylation could lead to MT network disruption and an increase in free
tubulin [23]. This information suggested to us that MAP4 might be
a protein potentially involved in regulating mitochondrial function
through the MT pathway. Here we performed experiments to
furtherdetermine the effect of MAP4on MTs and showedthat total
cytoplasmic tubulin was up-regulated, and MT networks are
enhanced in cells overexpressing MAP4 (Figure 1). These results
are in agreement with previous reports by Sato et al. and Cheng et
al. using adult cat CMs in vitro [21,30]. Furthermore, we found
dephosphorylated MAP4 overexpression could prevent MT
disruption in hypoxia (Figure 2). These observations suggest that
transient overexpression of MAP4 can be a protective factor to
MTs. In addition, the up-regulated MT production and observed
MT stabilization was associated with a relative maintenance of
cellular energy metabolism during the early stages (,180 min) of
hypoxia (Figure 5). These results suggest that inhibition of VDAC
by tubulin binding might modulate MMP and restrict outer
membrane permeability for ADP and ATP [31,32]. Our research
Figure 3. Interaction and co-localization of VDAC1, DYNLT1 and MTs. A, Example of Yeast two-hybrid technique. hVDAC1 was used as bait
to tag new target molecules (arrows indicate the positive results detailed in Table 1). B, A co-IP approach followed by immunoblot analysis was used
to test the protein-protein interaction between DYNLT1 and VDAC1. In whole-cell lysate of CMs and HeLa cells, abundant VDAC1 was detected in the
antigen-antibody complex when applying anti-DYNLT1 (Ab-go / Ab-ra) compared with using IC-go / IC-ra. Anti-VDAC1 antibody co-
immunoprecipitated with DYNLT1. IP- immunoprecipitate, IB- immunoblotting, Ab- antibody, IC- isotype control, go- goat, ra- rabbit. C,
Immunofluorescent confocal micrographs showing the co-localization between DYNLT1 (FITC-green) and VDAC1 (TRITC-red) in CMs. D, Confocal
micrographs showing the co-localization between DYNLT1 (FITC-green) and MTs (TRITC-red). Scale bar 10 mm. Areas in the boxed regions are shown
at higher magnification, scale bar 1 mm.
doi:10.1371/journal.pone.0028052.g003
Table 1. Tagging of interaction protein by yeast two-hybrid.
Bait Protein Prey Protein Prey Gene NCBI_AC Coding region ORF Report Gene Coding site
VDAC1 DYNLT1 Homo sapiens dynein,
light chain,1 (DYNLC1)
NM_006519 Yes yes LHU 1–559
VDAC1 APOB Homo sapiens apolipoprotein
B (including Ag(x) antigen)
(APOB)
NM_000384 Yes no HU 13340–13923
VDAC1 PTPRH Homo sapiens protein
tyrosine phosphatase, receptor
type, H (PTPR H), mRNA
NM_002842 Yes yes HU 2951–3539
doi:10.1371/journal.pone.0028052.t001
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VDAC1 and DYNLT1 are considered (see below).
MAP4 can modulate MTs to maintain mitochondrial function,
and VDAC acts as a crucial protein during this procedure. Using
Y2H technique(Figure 3A),we searched foraintermediate molecule
linking mitochondria (VDAC) and MTs, and came up with
DYNLT1 as a promising candidate (Figure 3B and 3C, Table 1).
Dynein light chain Tctex-type 1 (DYNLT1) assists the intermediate
chain,anothercomponentofdyneincomplex,tofulfillcargobinding
function [24,25], and plays a key role in multiple steps of
hippocampal neuron development, including initial neurite sprout-
ing, axon specification, and dendritic elaboration [33,34]. DYNLT1
actsinanindependentcargoadaptorrolefordyneinmotortransport
apart from other neuritogenic effects elicited by itself [35]. Although
numerousreportshave addressed dyneinsubunits,the mechanism of
how they function with other molecules in the cytosol remains
unclear. Schwarzer [27] reported on the protein-protein interactions
between DYNLT1 and VDAC1 and this was supported by our
immunofluorescence co-localization and immunoprecipitation ex-
periments (Figure 3B and 3C), accordingly, we speculate that
DYNLT1 may be one of the regulators of VDAC1. Based on the
above data, we presume that DYNLT1 is a potential intermediate
molecule, which can damage mitochondria via VDAC1 during the
course ofMTs disruption whenhypoxia. Thishypothesiswas further
strengthened by finding that there was a close association between
DYNLT1, VDAC1 and MTs in the cytosol (Figure 3C and 3D).
As shown in Figure 1B, MAP4 overexpression can constitutively
up-regulate tubulin, and, intriguingly, also heightens DYNLT1
expression in CMs and HeLa cells (Figure 4A). Our results posed
two additional questions: 1. Will overexpression or inhibition of
DYNLT1 effect mPT and energy metabolism during hypoxia? 2.
Is the beneficial potency of MAP4 overexpression on energy
metabolism due to the effect of MAP4 on DYNLT1? The western
blots indicated that although elevated expression of MAP4 led to
up-regulated expression of DYNLT1 and tubulin, DYNLT1
overexpression per se had no influence on tubulin and MAP4
levels (Figure 4C). However, DYNLT1-knockdown experiments
showed a dramatic increase in sensitivity to hypoxia with a
concomitant reduction in cell viability and MMP and mPT
damage (Figure 7). These findings suggest a previously unknown
mitochondrial mechanism of DYNLT1 regulation, possibly
governed by MAP4. Hypoxic damage will be aggravated with
the absence of DYNLT1, while its overexpression seems to have
no effect. Given the fact that DYNLT1 is associated with MTs and
interacts with VDAC, DYNLT1 regulation can be an independent
way for MAP4 to effect mitochondrial stabilization.
Figure 4. MAP4 overexpression leads to the elevated expression of DYNLT1. A, Immunoblot of DLNLT1 after MAP4 transfection. HeLa cells
with MAP4 overexpression (Ad-MAP4) showed an elevated expression of DYNLT1 compared with non-transfected cells (N) and Ad-GFP transfected
cells (Ad-GFP). # P,0.01 vs. N and Ad-GFP. B, Immunoblot of DYNLT1 after transient transfection of the plasmid. DYNLT1 was overexpressed in
pFLAG-DYNLT1 cells. * P,0.05 vs. pcDNA3.1-GFP. C, Immunoblot of MAP4 and a-tubulin following up-regulation of DYNLT1 (pFLAG-DYNLT1). There
seemed no influence on MAP4 and a-tubulin levels. Graphs represent the mean6SEM (n=3) of the relative optical density signals.
doi:10.1371/journal.pone.0028052.g004
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chondrial function in hypoxia (Figure 8): (1) MAP4 stabilizes MT
networks. (2) Overexpression MAP4 up-regulates DYNLT1,
which interacts with VDAC1, and thus hypoxia-induced mPT is
effectively inhibited. Although MAP4 overexpression only tempo-
rarily relieves energy dysmetabolism and enhances the cell’s
Figure 6. Verification of DYNLT1 knockdown in HeLa and H9c2 cell lines. H9c2 is a subclone of the original clonal cell line derived from
embryonic BD1X rat heart tissue; we chose H9c2 and HeLa cell lines to establish stable cell lines with low expression of DYNLT1 (2DYNLT1) by RNAi
technique. A, Immunoblot and quantified relative optical density analysis showed a stable low expression of DYNLT1 in cell clones using a RNAi
approach (DYNLT1-shRNA) compared with non-transfected cells (N) and control plasmid DNA transfected cells (Con-shRNA). Graph represents the
mean6SEM (n=3). # P,0.01 vs. N and Con-shRNA.
doi:10.1371/journal.pone.0028052.g006
Figure 5. MAP4 overexpression contributes to cellular viability (measured by MTT) and energy metabolism maintenance
(measured by ATP) during hypoxia. A, MTT reduction in +MAP4 groups (CMs and HeLa cells) was less when compared with Con (non-
transfected) cells. B, ATP reduction in +MAP4 groups was also less when compared with Con cells. Values were compared to normal values (Norm;
first bar), which were set to 100% and the other values normalized accordingly. Graph represents the mean6SEM (n=6, Separate six experiments) of
the relative luminescence signals. * P,0.05, # P,0.01 vs. Con.
doi:10.1371/journal.pone.0028052.g005
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cellular survival in cases of temporary severe hypoxia or hypoxia-
reoxygenation, and thus may contribute to functional organ
recovery in severe hypoxic-ischemic injury. However, there
remains much work to be done exploring the precise mechanisms
of MAP4 regulation, the interaction between tubulin and VDAC1,




All animal procedures were approved by the Institutional
Animal Care and Use Committee of the Third Military Medical
University (Permit Number SYXK-CQ-20070002) and adhered to
the Principles of Laboratory Animal Care (NIH publication).
Neonatal rat CMs were prepared according to the methods of
Lange et al. [36]. CMs from 1- to 3-day-old Sprague–Dawley rats
were plated at 5610
6 cells/60-mm dish and maintained for 48 h
in DMEM/F12 with 5-bromodeoxyuridine (BrdU, 31 mg/L;
Sigma), 10% (v/v) heat-inactivated fetal bovine serum (FBS),
penicillin G (100 U/ml), and streptomycin (100 mg/ml) before
hypoxia treatment. HeLa and H9c2 cell lines were obtained from
the American Type Culture Collection (ATCC Manassas, VA,
USA). HeLa cells were cultured in RPMI-1640 and H9c2 cultured
in DMEM under standard mammalian cell conditions.
Hypoxia treatment
Hypoxia was induced according to previous methods [37].
Briefly, hypoxic conditions were achieved by using an anaerobic
jar (Mitsubishi, Tokyo, Japan) and vacuum glove box (Chunlong,
Lianyungang, China). Serum-free medium was placed in a
Figure 7. DYNLT1 knockdown aggravates hypoxia-induced damage of mitochondria: mPT induction, MMP disruption and
reduction of cellular viability. A, 2DYNLT1 (RNAi by DYNLT1-shRNA) groups showed a sharp reduction in calcein fluorescence after 60 min of
hypoxia (cf. H30, H60 and H180); while +DYNLT1 (pFLAG-DYNLT1 transfected) cells showed no significant difference from WT (non-transfected) cells.
B, 2DYNLT1 cells showed a significant hypoxia-induced MMP damage, whereas +DYNLT1 cells appeared showed a slower decline in MMP that was
similar to WT cells. C, 2DYNLT1 cells showed a dramatic decrease in cell viability compared with WT and +DYNLT1 cells; WT and +DYNLT1 cells were
not significantly different. Values were compared to Norm (first bar), which was set at 100% and the other values were normalized accordingly.
Graphs represent the mean6SEM (n=6). * P,0.05, # P,0.01 vs. WT group or +DYNLT1 group.
doi:10.1371/journal.pone.0028052.g007
MAP4 Stabilizes mPT in Hypoxia via MTs and DYNLT1
PLoS ONE | www.plosone.org 9 December 2011 | Volume 6 | Issue 12 | e28052vacuum glove box filled with a gas mixture of 94% N2,5 %C O 2,
and 1% O2 (v/v) overnight and allowed to equilibrate with the
hypoxic atmosphere. Cells were subjected to hypoxic conditions by
replacing the normoxic medium with the hypoxic medium and the
culture dishes then placed in the anaerobic jar.
MAP4 recombinant adenovirus construction and
transfection
To induce MAP4 overexpression, we constructed a recombinant
adenovirus that expressed rat MAP4. The recombinant adenovi-
ruses were prepared using the Adeno-XTM system (BD ClonTech,
USA) according to the instructions. The transgene expression in
CMs and HeLa cells was tested by western blots. CMs were
maintained in DMEM/F12 and 10% FBS. HeLa cells were
maintained in RPMI-1640 and 5% FBS. The medium was changed
to medium without FBS, and cells were infected with adenoviruses
at a multiplicity of infection of 100–200 particles/cell for about
36 h. The cells were then cultured in DMEM/F12 or RPMI-1640
with FBS before morphological or biochemical analysis.
Immunofluorescence microscopy
Immunocytochemical staining was performed as described
previously [38,39]. Cells were cultured on coverslips (10-mm
diameter) and stained, and then five fields chosen on each coverslip
(2 across the top and bottom and 1 in the middle). After each
treatment, cells were rinsed twice in prewarmed (37uC) PBS and
then fixed in cold (220uC) methanol for 3 min and soaked three
times in cold acetone. Cells were rehydrated with PBS, blocked for
20 min with PBS containing 5% FCS and 0.1% bovine serum
albumin (BSA; Sigma), and then incubatedfor 60 minwith a mouse
primary antibody. For immunofluorescence microscopy, antibodies
were directed against MAP4 (1:500; BD Biosciences), a-tubulin
(1:1000; Santa Cruz Biotechnology, Santa Cruz, CA), DYNLT1
(1:500; Santa Cruz), VDAC1 (1:500; Santa Cruz Biotechnology).
Secondary antibodies used were FITC (fluorescein isothiocyanate) -
and TRITC (tetramethylrhodamine isothiocyanate)-conjugated
antibodies (Santa Cruz). Finally, counterstaining of nuclei was
performed with 4,6-diamidino-2-phenylindole (DAPI; Biotium,
Hayward, CA). The cells were observed and photographed with
LSM 510 META laser confocal scanning microscope (Carl Zeiss,
Germany). The fluorescence intensity of individual cells was
measured and analyzed with Image-Pro Plus 6.0 (Media Cyber-
netics, Inc. USA). We randomly chose one intact cell per field and
measured five cells per coverslip.Fourcoverslips(20cells)fromeach
time point for each group (Figure 2A and 2B) were analyzed by
immunofluorescence and the whole experiment repeatedly three
times (n=3).
DYNLT1 knockdown and establishment of stable cell
clones
To reduce DYNLT1 expression [40], HeLa and H9c2 cells were
seeded in 6-well plates in normal growth medium. Cells were grown
to 50–70% confluency in antibiotic-free normal growth medium
supplemented with FBS. A shRNA Plasmid DNA (shRNA strand
constructs against hDYNLT1: A) 59 - CUUCGGACUGU-
CUAUUUGA -39,B )5 9 -GAAGAAUGGAGCUGGAUUA-39
and C) 59 - CCACAAAUGUAGUAGAACA -39; sc-43319-SH,
Santa Cruz, USA) solution was added directly to the dilute shRNA
Plasmid Transfection Reagent (sc-108061, Santa Cruz). Cells were
washed twice with shRNA Transfection Medium (sc-108062, Santa
Cruz), and then 200 ml of shRNA Plasmid DNA/shRNA Plasmid
Transfection Reagent Complex added drop-wise in order to cover
the entire layer. Cells were incubated for 5–7 h at 37uCi naC O 2
incubator or under conditions normally used to culture the cells.
Following incubation, 1 ml of normal growth medium containing 2
times the normal serum and antibiotics (26 normal growth
medium) was added to the medium and the cells incubated for an
additional 18–24 hours under conditions normally used to culture
the cells. The control shRNA Plasmids (sc-108060, Santa Cruz)
encode a scrambled shRNA sequence that will not lead to the
specific degradation of any known cellular mRNA.
We used puromycin [41] to select stable transfected cells, as
follows: 48 hours post-transfection, the medium was aspirated and
replaced with fresh medium containing puromycin at the
appropriate concentration (2–4 mg/ml). Every 2–3 days the media
was aspirated and replaced with freshly prepared selective media.
The depletion levels of DYNLT1 were confirmed by Western
blotting. We named the stable cell clones that underwent
DYNLT1 knock-down as HeLa-dD and H9c2-dD.
Construction of plasmids and transfection
Full-length human DYNLT1 was subcloned into pFLAG
(pCMV-Tag 2C, Stratagene). Cell lines and control cell lines
were developed by electroporating cells with 20 mg of pFLAG-
DYNLT1 and pcDNA-3.1-GFP (control plasmid, ClonTech)
respectively with a single pulse of 1 ms at 200 V. After 2 days




TM two-hybrid system Kit (Invitrogen) was
used. The yeast strain MaV203 was transformed with pDBleu-
Figure 8. Model of MAP4, MTs and DYNLT1 interactions that
might prevent hypoxia-induced cell damage. The proposed
model was built to describe a different cell destiny with the absence
or presence of a hypothetical modulation during hypoxia. MAP4
overexpression may be a trigger in stabilizing mitochondrial function by
enhancing the structure of MTs and promoting DYNLT1 expression. We
demonstrated that DYNLTI interacts with VDAC1, which is considered
responsible for mPT and consequent cell death. MT enhancement
might be another potential mediator by binding tubulin to VDAC1 in
addition to its supporting role with mitochondria.
doi:10.1371/journal.pone.0028052.g008
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library (ProQuest
TM, Invitrogen) derived from human hepato-
cytes. Yeast cells were plated on selection plates lacking His and
Trp. Primary positive colonies were replaced and tested for LacZ
expression by filter assay. Prey plasmids of positive colonies were
recovered, transformed into E. coli, and sequenced. To reproduce
positive interactions in yeast, prey plasmids were re-transformed in
MaV203 together with pDBleu-hVDAC1 or with control bait
plasmids.
Western blot analysis
Whole cell lysate were prepared [42] and analyzed by western
blotting using primary antibodies to MAP4 (anti-MAP4 1: 500,
Bethyl), a-tubulin (anti-a-tubulin 1:1000, Santa Cruz), DYNLT1
(anti-DYNLT1 1:500, Santa Cruz) and VDAC1 (anti-VDAC
1:500, Santa Cruz). As a loading control, GAPDH was probed and
visualized. Immunocomplexes were visualized and quantified with
an enhanced chemiluminescence detection kit (Amersham Phar-
macia, Piscataway, NJ), using horseradish peroxidase-conjugated
secondary antibodies (1:2000; Santa Cruz).
Immunoprecipitation
To show the VDAC1 and DYNLT1 complex formation, CMs
and HeLa cells (60 mm dish) were lysed in 300 ml RIPA (Sigma)
buffer with 2 mM PMSF and a protease inhibitor cocktail. Anti-
DYNLT1 (E-16, goat polyclonal Ab; H-60, rabbit polyclonal Ab,
Santa Cruz) or anti-VDAC1 (FL-283 rabbit polyclonal Ab, Santa
Cruz) antibodies were incubated with 150 ml cell lysate for 6 h at
4uC. Afterward the complexes were precipitated with protein A/
G-Sepharose (Santa Cruz) overnight at 4uC. The precipitates were
washed 3 times with PBS at 0uC, then probed with anti-VDAC1
or anti-DYNLT1 antibodies by western blotting.
Quantification of ATP
CellTiter-Glo
TM Luminescent Cell Viability Assay kits were
used for ATP assay following the manufacturer’s instructions.
Briefly, treated cells were lysed in a 200 ml volume (4 mM EDTA,
0.2% Triton X-100) for 5 min; the assay buffer and substrate were
equilibrated to room temperature. In 96-well plates, 100 ml of the
assay reagent (25 mM HEPES pH 7.25, 300 mM Dluciferin,
5 mg/ml firefly luciferase, 75 mM DTT, 6.25 mM MgCl2,
625 mM EDTA and 1 mg/ml BSA) was added to each well and
the contents mixed for 2 min on an orbital shaker to induce cell
lysis. After 10 min incubation at room temperature, the lumines-
cence was read on a Microplate Reader. ATP levels were
standardized to cell number for protein levels using BCA assay.
Cell viability assay
Relative cell viability was determined using MTT (3-(4, 5-
dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide; 5 mg/ml
in PBS) [43], which was added at a final concentration of 125 mg/
ml after treatment. The cells were incubated with MTT for 3 h at
37uC, solubilized in dimethyl formamide (50%; v/v) and SDS
(20%; w/v), prior to absorbance measurements at 570 nm.
Determination of Mitochondrial Membrane Potential
Mitochondrial membrane potential (MMP) was assessed using
tetramethyl rhodamine methyl ester (TMRE, Invitrogen), a
lipophilic cationic fluorescent probe that becomes localized within
the mitochondria as a function of membrane potential [44,45].
Cells grown on coverslips were loaded with 500 nM TMRE for
30 min at 37uC in Hank’s balanced salt solution. Real time
imaging of live cells was performed with a fluorescence imaging
system (Leica DM6000 B, Leica, Germany). Dye loaded cells were
maintained in a perfusion chamber (bath volume=0.5 ml)
mounted on the microscope stage. For detection of fluorescence,
568 nm excitation and 585 nm emission filter settings were used.
Images were collected with an exposure time of 100 msec. Regions
of interest (ROI) were selected within several cells in each
experiment for measuring changes in MMP.
Mitochondrial permeability transition
The mPT was measured by calcein-AM / CoCl2 staining as
described previously by Petronilli et al [46,47]. Briefly, cells were
loaded with 1 mM calcein-AM ester and 1 mM CoCl2 in Hanks’
solution containing 10 mM Hepes buffer (pH 7.4) for 0.5 h at
37uC. Cells were washed to remove the free calcein and Co
2+, and
then analyzed using flow cytometry (Epics XL-MCL, BECK-
MAN, USA) with an excitation at 490 nm and emission at
520 nm.
Statistical analysis
Data are expressed as mean6SEM. SPSS 13.0 was used for
statistical analysis and significance evaluated by one-way ANOVA
followed by post-hoc tests and paired-samples T test. P
values,0.05 were considered statistically significant.
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